Garon and colleagues demonstrate that the association of HLA supertype B44 with response to immune checkpoint blockade in melanoma but not NSCLC is related to differential mutational features that influence HLA binding of neoepitopes.
- Amy L. Cummings
- Jaklin Gukasyan
- Edward B. Garon